tirzepatide inline New Access and Pricing Through Self-Pay Options Most Successful Weight Loss Program. Tirzepatide Unlikely to Exacerbate DR
Description
10.1136/bmjdrc-2016-000341
MOUNJARO KwikPen meets the current dose accuracy and functional requirements of ISO 11608-1
For the experimental group, participants had to be on a maintenance dose (at least 4 weeks, Supplemental Table 1) of a GLP-1RA medication for weight loss
Do not attempt this transition without direct clinical supervision
Hypoglycaemia risk is relatively low with Mounjaro monotherapy due to its glucose-dependent mechanism of action
